| Active ingredient (INN) | Canagliflozin |
|---|---|
| Brand names | Auro-Canagliflozin |
| ATC level 5 |
|---|
| A10BK02 |
| ATC level 4 | A10BK |
|---|
| Therapeutic category | Auto-created by Health Canada — Drug Shortages Database scraper |
|---|
| Controlled substance | No |
|---|
| Marketing-authorisation holders | AURO PHARMA INC, JAMP PHARMA CORPORATION, ANGITA PHARMA INC., SANDOZ CANADA INCORPORATED +1 more |
|---|
| Registrations on file | 5 |
|---|
| Patient information leaflet (PIL) | Not on file |
|---|
| Summary of product characteristics (SPC) | Not on file |
|---|
| Product | Strength | Form | Market | MA holder | Status |
|---|---|---|---|---|---|
| Auro-Canagliflozin | — | tablet | 🇨🇦 CA | AURO PHARMA INC | Active |
| Jamp Canagliflozin | — | tablet | 🇨🇦 CA | JAMP PHARMA CORPORATION | Active |
| Ag-Canagliflozin | — | tablet | 🇨🇦 CA | ANGITA PHARMA INC. | Active |
| Sandoz Canagliflozin | — | tablet | 🇨🇦 CA | SANDOZ CANADA INCORPORATED | Active |
| Apo-Canagliflozin | — | tablet | 🇨🇦 CA | APOTEX INC | Active |